DAVID WILLMAN is an investigative journalist whose work has prompted major public reforms—including a ban in 2005 of drug company payments to government scientists at the U.S. National Institutes of Health. Willman was awarded the Pulitzer Prize for Investigative reporting in 2001 for articles in the Los Angeles Times exposing how unsafe prescription drugs had been approved by the Food and Drug Administration. His reporting led to the market withdrawal of Rezulin, an aggressively promoted pill for Type 2 diabetes. Willman's many national honors include the top award bestowed by Investigative Reporters and Editors Inc., and, with colleagues, the George Polk Award. His work has also been recognized by the National Press Club, the Associated Press, and by Harvard University's John F. Kennedy School of Government. Willman's groundbreaking reporting in 2008 on the investigation of the deadly anthrax mailings was cited by the Scripps Howard Foundation as the year's best Washington-based coverage.